Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMIZLVW)

Drug Name

Phosphocholine Drug Info

Synonyms

phosphocholine; PHOSPHORYLCHOLINE; O-Phosphocholine; choline phosphate; phosphoryl-choline; CHOP; CHEBI:18132; N-Trimethyl-2-aminoethylphosphonate; N,N,N-trimethyl-2-(phosphonooxy)ethanaminium; Trimethyl(2-(phosphonooxy)ethyl)ammonium; Ethanaminium, N,N,N-trimethyl-2-(phosphonooxy)-; Phosphocholine cation; AC1L1AJH; Epitope ID:115009; SCHEMBL8012; n,n,n-trim ; thyl-2-(phosphonooxy) ; thanaminium; AC1Q29R5; CHEMBL1235161; CTK1B6465; YHHSONZFOIEMCP-UHFFFAOYSA-O; ZINC1532692; trimethyl(2-phosphonooxyethyl)azanium; DB03945; Choline, di

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

PubChem CID: 1014
ChEBI ID: CHEBI:18132
CAS Number: CAS 3616-04-4
TTD Drug ID: DMIZLVW

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting CRP messenger RNA (CRP mRNA)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
ISIS-CRPRx	DML84CN	Coronary artery disease	BA80	Phase 2	[2]
ISIS-CRP	DMQDUG4	Cardiovascular disease	BA00-BE2Z	Phase 1	[3]
ISIS 133726	DMJ56XU	Discovery agent	N.A.	Investigative	[4]
ISIS 133712	DMDZ3FU	Discovery agent	N.A.	Investigative	[4]
ISIS 140180	DMP9WOZ	Discovery agent	N.A.	Investigative	[4]
ISIS 330031	DM35WFL	Discovery agent	N.A.	Investigative	[4]
ISIS 330012	DMWIVS9	Discovery agent	N.A.	Investigative	[4]
ISIS 329956	DMA96KW	Discovery agent	N.A.	Investigative	[4]
------------------------------------------------------------------------------------


⏷ Show the Full List of 8 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
CRP messenger RNA (CRP mRNA)	TTWRN6M	CRP_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
2	Antisense oligonucleotides on neurobehavior, respiratory, and cardiovascular function, and hERG channel current studies. J Pharmacol Toxicol Methods. 2014 Jan-Feb;69(1):49-60.
3	Clinical pipeline report, company report or official report of ISIS Pharmaceuticals (2009).
4	US patent application no. 7,425,545, Modulation of C-reactive protein expression.